Moreover, the phosphorylation of MLC was reversed by the Rac1 inhibitor in a CCR4-dependant manner in HNSCC cells treated with CCL2 (Fig. 3H and Supplementary Fig. 4). Here, CCL2 is linked to head and neck squamous cell carcinoma.